Benzofuran derivative
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 1, 2008
Grant Date -
Aug 24, 2006
app pub date -
Mar 3, 2004
filing date -
Mar 7, 2003
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention is directed to a compound represented by formula (1): ##STR00001## (wherein R.sup.1 represents an alkyl group which may have a substituent or an alkenyl group which may have a substituent; andeach of R.sup.2 and R.sup.3 represents a hydrogen atom, an alkyl group, a hydroxyalkyl group, a dihydroxyalkyl group, or an alkynyl group, or R.sup.2 and R.sup.3 form, together with the nitrogen atom adjacent thereto, a nitrogen-containing saturated heterocyclic group which may have a substituent) and a drug composition containing the compound. The compound exhibits tumor necrosis factor (TNF-.alpha.) production inhibitory effect and improved absorption upon oral administration.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully